Ya Ding

5.1k total citations
140 papers, 4.1k citations indexed

About

Ya Ding is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Ya Ding has authored 140 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 36 papers in Oncology and 30 papers in Biomaterials. Recurrent topics in Ya Ding's work include Nanoparticle-Based Drug Delivery (26 papers), Gold and Silver Nanoparticles Synthesis and Applications (21 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Ya Ding is often cited by papers focused on Nanoparticle-Based Drug Delivery (26 papers), Gold and Silver Nanoparticles Synthesis and Applications (21 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Ya Ding collaborates with scholars based in China, United States and Canada. Ya Ding's co-authors include Xing‐Hua Xia, Can Zhang, Huai‐Song Wang, Vincent M. Rotello, Qineng Ping, Chang Soo Kim, Ryan F. Landis, Krishnendu Saha, Sung Tae Kim and Ziwen Jiang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Ya Ding

132 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya Ding China 35 1.4k 1.1k 1.1k 1.1k 587 140 4.1k
Ye Tian China 36 1.3k 0.9× 1.6k 1.4× 599 0.6× 1.2k 1.1× 357 0.6× 123 4.1k
Quan Zhou China 36 1.5k 1.1× 2.0k 1.8× 1.4k 1.3× 687 0.7× 487 0.8× 124 4.2k
Yi Hou China 35 1.4k 1.0× 2.4k 2.1× 1.2k 1.1× 2.1k 1.9× 307 0.5× 154 5.0k
Xiankai Sun United States 45 1.7k 1.2× 1.1k 1.0× 979 0.9× 1.4k 1.3× 985 1.7× 136 5.8k
Peng Zhang China 42 1.4k 1.0× 2.0k 1.7× 1.1k 1.1× 977 0.9× 459 0.8× 219 5.5k
Xiaohe Tian China 45 2.0k 1.4× 2.1k 1.8× 794 0.7× 2.5k 2.4× 618 1.1× 241 6.9k
Xuewu Liu United States 43 1.9k 1.4× 2.6k 2.2× 1.6k 1.5× 1.4k 1.4× 370 0.6× 135 5.3k
Ming Wu China 40 1.6k 1.2× 2.8k 2.4× 1.2k 1.1× 1.3k 1.3× 522 0.9× 103 4.9k
Min Xue China 33 2.0k 1.4× 1.6k 1.4× 1.8k 1.7× 1.6k 1.5× 504 0.9× 95 5.2k
Zhe Yang China 44 2.6k 1.8× 2.3k 2.0× 1.2k 1.2× 1.1k 1.0× 622 1.1× 195 6.6k

Countries citing papers authored by Ya Ding

Since Specialization
Citations

This map shows the geographic impact of Ya Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya Ding more than expected).

Fields of papers citing papers by Ya Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya Ding. The network helps show where Ya Ding may publish in the future.

Co-authorship network of co-authors of Ya Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ya Ding. A scholar is included among the top collaborators of Ya Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya Ding. Ya Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nie, Run‐Cong, Ya Ding, Shuqiang Yuan, et al.. (2024). Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4083–4083. 1 indexed citations
3.
Li, Dandan, Chao Chen, Jingjing Li, et al.. (2023). A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors. Nature Communications. 14(1). 3447–3447. 6 indexed citations
4.
Wang, Yuhan, et al.. (2023). Metal/covalent-organic framework-based biosensors for nucleic acid detection. Coordination Chemistry Reviews. 491. 215249–215249. 45 indexed citations
5.
Yang, Hao, et al.. (2023). In-vial solid-phase extraction of polycyclic aromatic hydrocarbons in drug formulations stored in packaging containing rubber. RSC Advances. 13(12). 7848–7856. 2 indexed citations
6.
Cheng, Yaonan, et al.. (2022). Simulation and experimental study of tool wear and damage in milling SA 508III steel. Surface Topography Metrology and Properties. 10(3). 35033–35033. 3 indexed citations
7.
Yin, Li, et al.. (2022). Enzyme‐Immobilized Metal‐Organic Frameworks: From Preparation to Application. Chemistry - An Asian Journal. 17(21). e202200751–e202200751. 22 indexed citations
8.
Wang, Wenjie, Xianzhi Zhang, Rui Huang, et al.. (2021). In situ activation of therapeutics through bioorthogonal catalysis. Advanced Drug Delivery Reviews. 176. 113893–113893. 96 indexed citations
9.
Lee, Lena J., Leslie Wehrlen, Ya Ding, & Alyson Ross. (2021). Professional quality of life, sleep disturbance and health among nurses: A mediation analysis. Nursing Open. 9(6). 2771–2780. 20 indexed citations
10.
Song, Shuangshuang, et al.. (2019). PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Liu, Aiyun, et al.. (2016). Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system. 47(5). 542. 2 indexed citations
12.
Ding, Ya. (2014). Formation control for multiple UAVs with time delay based on consensus algorithm. Journal of Computer Applications. 1 indexed citations
13.
Ding, Ya. (2014). Characteristic analysis of heat transfer and pressure drop on fuel cell engine radiator. Chinese Journal of Power Sources. 1 indexed citations
14.
Ding, Ya, Ziwen Jiang, Krishnendu Saha, et al.. (2014). Gold Nanoparticles for Nucleic Acid Delivery. Molecular Therapy. 22(6). 1075–1083. 407 indexed citations
15.
Wang, Yao, Rui-Qing Peng, Dandan Li, et al.. (2011). Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells. Chinese Journal of Cancer. 30(10). 690–700. 54 indexed citations
16.
Ding, Ya. (2011). The current status and influencing factors of quality of life in patients with cervical cancer. Zhonghua huli zazhi. 1 indexed citations
17.
Zhao, Weifeng, et al.. (2011). Mechanism of Anoikis Resistance Mediated by PYK2 in H460 Lung Carcinoma Cells. Journal of Sun Yat-sen University. 32(3). 297. 1 indexed citations
18.
Ding, Ya. (2003). Thermodynamic Calculation of Precipitates and Optimization of Strengthening Technology of Maraging Stainless Steel S-04. Gangtie yanjiu xuebao. 1 indexed citations
19.
Ding, Ya. (2002). Studies on Simultaneously Detecting Multiple Antibodies in The Serum Using Microarray. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 1 indexed citations
20.
Ding, Ya. (2002). Ant Colony Algorithm in Chemistry and Its Application in First Derivative Fluorescent Spectra Analyzing. Chemical Research in Chinese Universities. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026